Track Insider Trading in Facebook, Zynga, Arena Pharmaceuticals, Lululemon Athletica, Weatherford International, and Bank of America
HONG KONG, Sept. 13, 2013 /PRNewswire/ -- Insiderslab.com is has released insider trading report for US market investors to track the performance of company insiders, which can help the portfolios. Today's report will cover the following stocks: Facebook (NASDAQ: FB), Zynga (NASDAQ: ZNGA), Arena Pharmaceuticals (NASDAQ: ARNA), Lululemon Athletica (NASDAQ: LULU), Weatherford International (NYSE: WFT), and Bank of America (NYSE: BAC).
(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)
Facebook Inc (NASDAQ: FB)): By the end of last trading session, the shares of Facebook (NASDAQ: FB) lost US$0.29 (or 0.64%) to US$44.75 with 68.05 million shares exchanged hands, compared to daily average volume of 65.38 million. Insiderslab.com found company VP Marketing & Bus. Part., David B. Fischer, sold his shares at the price of US$43.38 on September 11. One day before, the company Chief Operating Officer, Sheryl Sandberg, sold her shares at the price of US$43.69, which was part of her US$123.10 million selling within last three months. Investors may want to find out how Facebook insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for FB here.
Read Full Report: http://www.insiderslab.com/PR3/091313A/FB/Facebook.pdf
Zynga Inc (NASDAQ: ZNGA): By the end of last trading session, Zynga (NASDAQ: ZNGA) shares earned 0.67% to US$3.02 with about 14.74 million shares exchanged hands for the session, compared to its average volume of 15.65 million shares. Insiderslab.com found company Directors, Stanley J. Meresman and Jeffrey Katzenberg, sold their shares at the price of US$2.86 on September 3. Investors may want to find out how Zynga insiders like CEOs, CFOs and Directors are thinking about the future of the company.
Read Full Report: http://www.insiderslab.com/PR3/091313A/ZNGA/Zynga.pdf
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA): By the end of last trading session, Arena Pharmaceuticals (NASDAQ: ARNA) dropped 2.57% to US$5.87 with about 9.45 million shares exchanged hands for the session, compared to its average volume of 4.61 million shares. Insiderslab.com found company EVP & Chief Scientific Officer, Dominic P. Behan, sold his shares at the price of US$6.31 for about US$1.26 million on September 10. Insiderslab.com believes that it is a clever way to check if insiders like CEOs, CFOs, and Directors in Arena are starting to sell more company shares. See insider trade report for ARNA here.
Read Full Report: http://www.insiderslab.com/PR3/091313A/ARNA/Arena.pdf
Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.
Lululemon Athletica inc. (NASDAQ: LULU):
Read Full Report: http://www.insiderslab.com/PR3/091313A/LULU/LululemonAthletica.pdf
Weatherford International Ltd (NYSE: WFT):
Read Full Report: http://www.insiderslab.com/PR3/091313A/WFT/Weatherford.pdf
Bank of America Corp (NYSE: BAC):
Read Full Report: http://www.insiderslab.com/PR3/091313A/BAC/BankofAmerica.pdf
Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.
Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore. Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.
Please visit insiderslab.com/disclaimers/disclaimers.php for details.
SOURCE Insiderslab.com; Insiders.hk